Specific keynote: clinical trial design problems in ovarian cancer

Delphi approach to prioritising research in cardiovascular and kidney disease using routinely collected data.

BMJ open·2026

Generalism as a cross-disciplinary practice in medicine: Mixed-studies systematic review.

Canadian family physician Medecin de famille canadien·2026

Health impact assessments should be mandatory for all relevant government policies.

Health policy (Amsterdam, Netherlands)·2025

Systematic review of evidence for the impact and effectiveness of the 1-3-7 strategy for malaria elimination.

Malaria journal·2024

COVID-19 risk by work-related factors: pooled analysis of individual linked data from 14 cohorts.

Occupational and environmental medicine·2024

Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years.

Heart (British Cardiac Society)·2024

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Gynecologic oncology·2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Gynecologic oncology·2026

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Gynecologic oncology·2026

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Gynecologic oncology·2026

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Gynecologic oncology·2026

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Gynecologic oncology·2026

Unraveling the epigenetic code in cancer cell-tumor microenvironment crosstalk.

Molecular oncology·2026

Molecular mechanisms of therapeutic resistance in areca nut-associated oral squamous cell carcinoma: the interplay of chronic inflammation and epithelial-mesenchymal transition.

Frontiers in oncology·2026

Rapid normal fibroblast-tumor crosstalk promotes cancer-associated fibroblast-like activation and attenuates mitomycin C cytotoxicity in bladder cancer.

Journal of cell communication and signaling·2026

Deciphering the malignant synergy: metabolic reprogramming, epigenetic circuitry, and niche remodeling in osteosarcoma-macrophage crosstalk.

Frontiers in immunology·2026

Optimization of a Canine Colon Organoid Platform for Modeling Intestinal Injury and Mesenchymal Stem Cell-Mediated Regeneration.

International journal of stem cells·2026

Loss of Erbin in tubular epithelial cells sensitizes mice to acute kidney injury and aggravates renal fibrosis.

The EMBO journal·2026

Related Experiment Videos

Specific keynote: clinical trial design problems in ovarian cancer

Related Concept Videos

Delphi approach to prioritising research in cardiovascular and kidney disease using routinely collected data.

Generalism as a cross-disciplinary practice in medicine: Mixed-studies systematic review.

Health impact assessments should be mandatory for all relevant government policies.

Systematic review of evidence for the impact and effectiveness of the 1-3-7 strategy for malaria elimination.

COVID-19 risk by work-related factors: pooled analysis of individual linked data from 14 cohorts.

Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years.

Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.

Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old).

Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?

Feedback activation of MAPK-ERK1/2 signaling causes resistance to trastuzumab-deruxtecan in endometrial cancers.

Unraveling the epigenetic code in cancer cell-tumor microenvironment crosstalk.

Molecular mechanisms of therapeutic resistance in areca nut-associated oral squamous cell carcinoma: the interplay of chronic inflammation and epithelial-mesenchymal transition.

Rapid normal fibroblast-tumor crosstalk promotes cancer-associated fibroblast-like activation and attenuates mitomycin C cytotoxicity in bladder cancer.

Deciphering the malignant synergy: metabolic reprogramming, epigenetic circuitry, and niche remodeling in osteosarcoma-macrophage crosstalk.

Optimization of a Canine Colon Organoid Platform for Modeling Intestinal Injury and Mesenchymal Stem Cell-Mediated Regeneration.

Loss of Erbin in tubular epithelial cells sensitizes mice to acute kidney injury and aggravates renal fibrosis.

Related Experiment Videos

Specific keynote: clinical trial design problems in ovarian cancer

Related Concept Videos

Related Articles